Please provide your email address to receive an email when new articles are posted on . 37.4% of patients with Fitzpatrick skin types IV to VI and 38.7% of the total ...
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive ...
Please provide your email address to receive an email when new articles are posted on . After 12 weeks, researchers observed a 23.4% improvement in overall photodamage in Fitzpatrick skin types I to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results